Opinion|Videos|May 26, 2025
Key Takeaways to Prioritize in Practice
Author(s)Adam James, PharmD
A panelist discusses key insights for pharmacists to prioritize, including staying informed about new respiratory syncytial virus (RSV) vaccines such as Arexvy and Abrysvo, educating patients on the benefits of vaccination, monitoring common adverse effects, ensuring timely access to vaccines, and playing a crucial role in supporting patient safety and prevention efforts for RSV.
Advertisement
Episodes in this series
Summary for Physicians: Key insights for pharmacists to prioritize include the following:
- Vaccine Awareness: Stay informed about new RSV vaccines such as Arexvy and Abrysvo, especially for high-risk groups such as older adults and pregnant individuals.
- Patient Education: Educate patients about the benefits of vaccination, particularly in preventing severe RSV infections in vulnerable populations.
- Monitor Safety: Be aware of common vaccine adverse effects (eg, injection site soreness and mild fever) and help manage them effectively.
- Vaccine Access: Ensure that patients have access to the newest vaccines and understand the importance of timely administration.
Pharmacists play a crucial role in vaccine education, administration, and supporting patient safety in RSV prevention.
Advertisement
Related to this article
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
4
Semaglutide Normalized Liver Fat in Most Adults With Obesity
5